Chemours reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Chemours using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-04 | $0.40 | $0.28 | 42.9 % |
Jun 2024 | 2024-08-01 | $0.38 | $0.57 | -33.3 % |
Mar 2024 | 2024-04-30 | $0.32 | $0.18 | 77.8 % |
Dec 2023 | 2024-03-27 | $0.31 | $0.25 | 24.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-04 | $1.50B | $1.44B | 4.24 % |
Jun 2024 | 2024-08-01 | $1.54B | $1.53B | 0.52 % |
Mar 2024 | 2024-04-30 | $1.35B | $1.35B | 0.00 % |
Dec 2023 | 2024-03-27 | $1.36B | $1.32B | 3.11 % |
Chemours ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 4, 2024 for Q3.
Chemours ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 4, 2024 for Q3 and the Actual EPS was $0.40, which beat the estimate of $0.28.
Chemours ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 4, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.